On ECHEMI
Home > Drugs > Cisen Pharmaceutical Co., Ltd.

Cisen Pharmaceutical Co., Ltd.

  • Founded in:

    1998-11-06
  • Country:

    China China
  • Address:

    Tongji Science and Technology Industrial Park, Jining High-tech Zone
  • Tax NO.:

    91370800706117999P
  • Registered Funds:

    452,754,129 yuan
  • Website:

  • Email:

Related Drugs
Docetaxel Injection
Dominican Republic
Name Description Content CAS NO. Registered Holders
Docetaxel

Docetaxel is a paclitaxel anti-tumor drug that exerts its anti-tumor effect by interfering with the microtubule network necessary for cell mitosis and interphase cell function. Docetaxel can bind to free tubulin, promote tubulin assembly into stable microtubules, and inhibit its depolymerization, resulting in the production of microtubule bundles that have lost their normal functions and the fixation of microtubules, thereby inhibiting cell mitosis. The binding of docetaxel to microtubules does not change the number of protofilaments. This is different from most spindle toxic drugs currently used in clinical practice.

More

Docetaxel is a paclitaxel anti-tumor drug that exerts its anti-tumor effect by interfering with the microtubule network necessary for cell mitosis and interphase cell function. Docetaxel can bind to free tubulin, promote tubulin assembly into stable microtubules, and inhibit its depolymerization, resulting in the production of microtubule bundles that have lost their normal functions and the fixation of microtubules, thereby inhibiting cell mitosis. The binding of docetaxel to microtubules does not change the number of protofilaments. This is different from most spindle toxic drugs currently used in clinical practice.

114977-28-5 49
Citicoline Sodium Injection
Its chemical name is: monosodium salt of choline cytosine diphosphate.
Name Description Content CAS NO. Registered Holders
Choline cytosine diphosphate monosodium salt

It promotes brain metabolism and improves brain circulation by reducing cerebrovascular resistance and increasing cerebral blood flow. It also enhances the function of the ascending activation system of the brainstem reticular structure, the function of the pyramidal system, improves motor paralysis, and promotes the recovery of brain function and awakening.

More

It promotes brain metabolism and improves brain circulation by reducing cerebrovascular resistance and increasing cerebral blood flow. It also enhances the function of the ascending activation system of the brainstem reticular structure, the function of the pyramidal system, improves motor paralysis, and promotes the recovery of brain function and awakening.

0
Vitamin B1 tablets
Each tablet of this product contains the main ingredient vitamin B110 mg, and the auxiliary ingredients are starch, dextrin, sucrose, medicinal calcium sulfate, citric acid, sodium lauryl sulfate, and magnesium stearate.
Name Description Content CAS NO. Registered Holders
Thiamine chloride

It combines with adenosine triphosphate to form vitamin B1 pyrophosphate (thiamine diphosphate, cocarboxylase), which is a coenzyme necessary for carbohydrate metabolism; it can inhibit the activity of cholinesterase. When it is deficient, the activity of cholinesterase is enhanced, the hydrolysis of acetylcholine is accelerated, causing nerve impulse conduction disorders, and affecting gastrointestinal and myocardial function.

More

It combines with adenosine triphosphate to form vitamin B1 pyrophosphate (thiamine diphosphate, cocarboxylase), which is a coenzyme necessary for carbohydrate metabolism; it can inhibit the activity of cholinesterase. When it is deficient, the activity of cholinesterase is enhanced, the hydrolysis of acetylcholine is accelerated, causing nerve impulse conduction disorders, and affecting gastrointestinal and myocardial function.

10mg 59-43-8 9
Sodium Fructose Diphosphate for Injection
Name Description Content CAS NO. Registered Holders
D-fructose 1,6-bis(dihydrogen phosphate)

Extract from the above information

More

Extract from the above information

488-69-7 9
Sodium Fructose Diphosphate for Injection
Name Description Content CAS NO. Registered Holders
D-fructose 1,6-bis(dihydrogen phosphate)

No specific pharmacological effects mentioned

More

No specific pharmacological effects mentioned

488-69-7 9
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.